May 13, 2021 at 09:48PM Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA

Draft guidance for industry and FDA Staff: Submissions for Postapproval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TKf08L